GENOVESE, Filippo
 Distribuzione geografica
Continente #
NA - Nord America 4.488
EU - Europa 3.806
AS - Asia 2.584
SA - Sud America 405
AF - Africa 55
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.345
Nazione #
US - Stati Uniti d'America 4.381
GB - Regno Unito 1.387
IT - Italia 988
SG - Singapore 763
CN - Cina 636
DE - Germania 330
BR - Brasile 319
VN - Vietnam 308
HK - Hong Kong 296
SE - Svezia 238
FR - Francia 167
RU - Federazione Russa 128
BD - Bangladesh 117
FI - Finlandia 111
PL - Polonia 103
KR - Corea 84
UA - Ucraina 80
IN - India 67
TR - Turchia 64
CA - Canada 60
JP - Giappone 60
ID - Indonesia 42
NL - Olanda 42
BE - Belgio 32
BG - Bulgaria 32
AR - Argentina 29
IQ - Iraq 27
MX - Messico 27
IE - Irlanda 26
PK - Pakistan 22
CH - Svizzera 21
LT - Lituania 21
ES - Italia 19
AT - Austria 18
ZA - Sudafrica 16
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
DK - Danimarca 11
PY - Paraguay 11
CO - Colombia 10
EC - Ecuador 10
MY - Malesia 10
VE - Venezuela 9
JO - Giordania 8
MA - Marocco 8
CL - Cile 7
LI - Liechtenstein 6
PE - Perù 6
PH - Filippine 6
SA - Arabia Saudita 6
CR - Costa Rica 5
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
PS - Palestinian Territory 5
AU - Australia 4
AZ - Azerbaigian 4
BH - Bahrain 4
GR - Grecia 4
GT - Guatemala 4
KE - Kenya 4
KZ - Kazakistan 4
NO - Norvegia 4
PT - Portogallo 4
TW - Taiwan 4
TZ - Tanzania 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
NG - Nigeria 3
RS - Serbia 3
TN - Tunisia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CG - Congo 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 11.337
Città #
Southend 1.170
Ashburn 482
Santa Clara 468
Singapore 456
Chandler 292
Hong Kong 286
Fairfield 261
San Jose 233
Woodbridge 219
Hefei 187
Ann Arbor 185
Houston 165
Nyköping 136
Dearborn 135
Jacksonville 125
Frankfurt am Main 115
Wilmington 112
Beijing 105
Cambridge 105
Modena 100
London 96
Seattle 95
Ho Chi Minh City 85
Council Bluffs 84
Los Angeles 84
New York 83
Kraków 77
Hanoi 73
Seoul 70
Helsinki 67
The Dalles 65
Milan 63
Tokyo 57
Shanghai 41
Munich 35
Orem 35
Bologna 33
Princeton 32
Sofia 32
Buffalo 31
Fremont 31
Lauterbourg 31
Moscow 31
Chicago 29
Jakarta 29
Rome 29
San Diego 29
Eugene 26
Izmir 26
Boardman 23
Dublin 23
Da Nang 22
Porto Alegre 21
Brussels 20
São Paulo 20
Warsaw 20
Redwood City 19
Dallas 18
Lahore 17
Padova 17
Atlanta 15
Parma 15
Phoenix 15
Turku 15
San Gimignano 14
Rio de Janeiro 13
Stockholm 13
Bremen 12
Montreal 12
Nuremberg 12
Paris 12
Reggio Emilia 12
Toronto 12
Amsterdam 11
Des Moines 11
Ferrara 11
Naples 11
Brno 10
Brooklyn 10
Chennai 10
Johannesburg 10
Vienna 10
Denver 9
Guangzhou 9
Haiphong 9
Prato 9
Tashkent 9
Charleston 8
Columbus 8
Jinan 8
Ottawa 8
Salt Lake City 8
Zurich 8
Amman 7
Belo Horizonte 7
Calcinaia 7
Elk Grove Village 7
Kent 7
Mexico City 7
Mumbai 7
Totale 7.464
Nome #
Oxytetracycline-Protein Complex: The Dark Side of Pet Food 774
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 461
Enamel peptides reveal the sex of the Late Antique ‘Lovers of Modena’ 446
Metodo per la funzionalizzazione sito specifica di molecole proteiche 430
An autoregulatory loop controls the expression of the transcription factor NF-Y 426
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 406
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 395
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 394
Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides 368
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 363
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 362
Allosteric Inhibition of human Thymidylate Synthase. 357
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 347
A proteomic approach to investigate the mechanism of action of anticancer peptides 342
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 342
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 331
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 293
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 286
Chairperson EUTROC- Mayo Conference-Berlin - Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cell models. 286
Design, synthesis and biological evaluation of non-covalent AmpC Beta-Lactamases inhibitors 285
Invited lecture to 18th World Congress on Advances in Oncology and 16th International Symposium on Molecular Medicine 10-12 October, 2013, Creta Maris, Hersonissos, Crete, Greece 282
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 278
MALDI-TOF MS as a tool for rapid Identification of Low Protein Affinity Drug Fragments. 270
Discovery and preliminary characterization of a novel inhibitor of the SOS response in Pseudomonas aeruginosa 268
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 260
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 245
EVALUATION OF LR STABILITY BY LC CHIP Q-TOF AND QUANTITATIVE DETERMINATION OF LR PEPTIDE CELL PENETRATION BY LC-MS/MS 244
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 242
Merging disulphide bonds for drug design Interfering with a cancer key protein 226
A dual-Omics approach to identify the modulated proteins/genes in THP-1 cells infected with different drug resistant L. infantum clinical isolates. 224
Development and validation of a new storage procedure to extend the in-use stability of azacitidine in pharmaceutical formulations 206
Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates 180
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 173
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 171
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 166
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 165
Quantitative comparison of the protein corona of nanoparticles with different matrices 141
Totale 11.435
Categoria #
all - tutte 35.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/2022681 39 82 41 43 27 48 56 38 60 40 120 87
2022/2023891 95 121 60 91 81 109 38 118 70 12 53 43
2023/2024911 30 37 41 71 223 73 156 87 22 26 58 87
2024/20252.050 78 29 74 157 376 274 182 125 190 83 214 268
2025/20263.385 237 135 218 370 536 241 457 184 292 339 232 144
Totale 11.435